Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival-Reference-Cited by-同舟云学术

Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival

Published:2021-09 Issue:9 Volume:21 Page:598-605
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Ali M.M.,Grønvold B.,Remberger M.,Abrahamsen I.W.,Myhre A.E.,Tjønnfjord G.E.,Fløisand Y.,Gedde-Dahl T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference45 articles.

1. Haematopoietic cell transplantation as immunotherapy;Appelbaum;Nature,2001

2. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults;Sorror;Hematology Am Soc Hematol Educ Program,2014

3. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry;Socié;N Engl J Med,1999

4. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report;Filipovich;Biol Blood Marrow Transplant,2005

5. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation;Martin;J Clin Oncol,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience;Hematology Reports;2024-04-17

2. Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors;eJHaem;2024-02

3. Use of antithymocyte globulin (rabbit) in a patient with known alpha-gal syndrome undergoing allogenic stem cell transplantation;Journal of Oncology Pharmacy Practice;2023-11-07

4. Controversies and expectations for the prevention of GVHD: A biological and clinical perspective;Frontiers in Immunology;2022-11-23

5. Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes;Current Opinion in Infectious Diseases;2021-09-16